WASHINGTON, Oct. 13, 2025 /PRNewswire/ — The International Union for Conservation of Nature (IUCN) issued a decision on October 9, 2025, to retain the “Endangered” status determination for long-tailed macaque (“LTM”) monkeys (Macaca fascicularis). The […]
Resilience
DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call
DENVER, Oct. 13, 2025 /PRNewswire/ — DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Wednesday, October 29, 2025, at 5:00 p.m. Eastern Time. The company plans to […]
Nuvalent to Present New Preclinical Data for HER2-Selective Inhibitor, NVL-330, at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
CAMBRIDGE, Mass., Oct. 13, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced an upcoming poster presentation further characterizing the preclinical intracranial […]
NORD Breakthrough Summit Features Bold New Ideas for the Future of Rare Disease Care, Policy and Research
Lightning round poster presentations highlight cutting-edge insights on issues ranging from Medicaid coverage disparities to real-world data innovation WASHINGTON, Oct. 13, 2025 /PRNewswire/ — The future of rare disease advancements will take center stage at […]
ADC Therapeutics Announces $60 Million Private Placement
LAUSANNE, Switzerland, Oct. 13, 2025 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it has entered into securities purchase agreements for […]